Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Stock
Stocks
002399
CNE100000P02
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shenzhen S.E.
2026-09-03
|
5-day change | 1st Jan Change | ||
| 9.890 CNY | -0.80% |
|
-4.90% | -16.12% |
| Market Cap | 13.14B 1.95B 1.69B 1.59B 1.45B 2.71B 185B 2.73B 18.81B 7.3B 94.41B 7.34B 7.18B 310B | P/E 2026 * |
17.1x | P/E 2027 * | 14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 11.71B 1.74B 1.5B 1.42B 1.29B 2.41B 165B 2.43B 16.76B 6.51B 84.16B 6.54B 6.4B 276B | EV / Sales 2026 * |
2.03x | EV / Sales 2027 * | 2.2x |
| Free-Float |
14.33% | Yield 2026 * |
0.71% | Yield 2027 * | 0.81% |
| 1 day | -0.80% | ||
| 1 week | -4.90% | ||
| Current month | -1.49% | ||
| 1 month | +2.06% | ||
| 3 months | +1.12% | ||
| 6 months | -15.97% | ||
| Current year | -16.12% |
| 1 week | 9.89 |  | 10.59 |
| 1 month | 9.57 | | 11.57 |
| Current year | 8.5 | | 12.64 |
| 1 year | 8.5 | | 13.33 |
| 3 years | 6.89 | | 14.34 |
| 5 years | 6.89 | | 18.89 |
| 10 years | 6.89 | | 30.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yu Shan
CEO | Chief Executive Officer | 65 | 1998-04-20 |
Tan Li
PRN | Corporate Officer/Principal | 61 | 1998-04-20 |
Juan Chen
DFI | Director of Finance/CFO | 51 | 2023-08-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Tan Li
BRD | Director/Board Member | 61 | 1998-04-20 |
Li Li
CHM | Chairman | 62 | 1998-04-20 |
Yu Shan
BRD | Director/Board Member | 65 | 1998-04-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/23/23 | Sell | 11,200 | 0.0009% | |||
| 5/26/21 | Other | Chief Financial Officer | 459,588 | 0.2088% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.80% | -4.90% | -23.33% | -15.83% | 1.97B | |
| -0.56% | -1.89% | +56.39% | +106.72% | 1,034B | |
| +0.76% | +4.25% | +55.65% | +72.43% | 663B | |
| -0.47% | +0.70% | +22.70% | +77.93% | 462B | |
| +2.46% | -1.90% | +32.50% | +38.60% | 344B | |
| +0.18% | +5.42% | +27.47% | +47.59% | 307B | |
| +1.34% | +0.05% | -0.74% | +13.38% | 251B | |
| -0.07% | +1.37% | +56.06% | +74.39% | 239B | |
| -0.03% | +2.18% | -17.26% | -53.97% | 207B | |
| +0.16% | +0.47% | +32.37% | +98.99% | 186B | |
| Average | +0.34% | -1.16% | +24.18% | +46.02% | 369.53B | |
| Weighted average by Cap. | +0.30% | -0.84% | +38.14% | +67.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.78B 859M 741M 698M 636M 1.19B 81.18B 1.2B 8.27B 3.21B 41.51B 3.23B 3.16B 136B | 6.27B 934M 805M 759M 691M 1.29B 88.2B 1.3B 8.98B 3.49B 45.09B 3.51B 3.43B 148B |
| Net income | 574M 85.44M 73.71M 69.43M 63.26M 118M 8.07B 119M 822M 319M 4.13B 321M 314M 13.55B | 596M 88.74M 76.56M 72.12M 65.71M 123M 8.38B 124M 854M 331M 4.29B 333M 326M 14.08B |
| Net Debt | -1.43B -212M -183M -173M -157M -294M -20.06B -296M -2.04B -793M -10.25B -797M -780M -33.69B | 668M 99.36M 85.71M 80.74M 73.57M 138M 9.39B 139M 956M 371M 4.8B 373M 365M 15.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | CN¥9.890 | -0.80% | 4,148,042 |
| 26-09-02 | CN¥9.970 | -1.09% | 4,488,328 |
| 26-09-01 | CN¥10.08 | +0.40% | 5,827,285 |
| 26-08-31 | CN¥10.04 | -3.92% | 7,688,460 |
| 26-08-28 | CN¥10.45 | -1.42% | 5,347,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 002399 Stock
Select your edition
All financial news and data tailored to specific country editions
